EASL to carry special meeting on therapy of HCV The European Association for the Study of the Liver.

This is vitally important for physicians who are needs to use the drugs, particularly when it comes to which patients should right now be treated, said Prof. Dr. Heiner Wedemeyer. Moreover, Prof. Dr. Wedemeyer said perspectives on Interferon free of charge treatment regimens will become extremely exciting: After a lot more than 25 years, we can develop therapies that will not require IFN-alpha now, which causes many side-effects and is quite expensive also. We are experiencing a paradigm shift in the therapy of hepatitis C. This conference shall also be very important for the advancement of new guidelines in Europe! .. AASLD, EASL to carry special meeting on therapy of HCV The European Association for the Study of the Liver , together with the American Association for the analysis of Liver Diseases , will be holding an exciting Special Conference focused on the timely topic of: Therapy of Hepatitis C: Clinical Application and Drug Development During the three days of the conference – held from 14-16 September 2012 in Prague, Czech Republic leading international Hepatitis C experts will highlight and address a series of lectures, and take part in interactive debates on hop topics in Hepatitis C.What explains the bigger risks? It’s not clear from the study, but Devereaux speculated on some good reasons. For just one, the fracture itself creates swelling, a tension response from the anxious system, and a tendency for bloodstream cells to create clots. On top of that, Devereaux said, hip-fracture sufferers are immobile rather than eating ahead of surgery, which in turn causes muscle breakdown and deconditioning quickly. A potential way to handle those presssing issues, Devereaux said, is through quicker surgery.